EP20: Post‑Thrombotic Syndrome: The Long Road After Deep Vein Thrombosis

Our 20th article explores Post‑Thrombotic Syndrome, a common yet often underestimated consequence of DVT, which can develop in up to 50% of patients despite appropriate anticoagulation. Join us in raising awareness and advancing patient care!

At Werfen, our mission of Powering Patient Care includes advancing understanding of thrombotic diseases and their long‑term consequences. This episode focuses on Post‑Thrombotic Syndrome (PTS), a frequent and often underestimated complication of deep vein thrombosis (DVT), characterized by chronic venous insufficiency and persistent venous hypertension.

Introduction

PTS is a chronic consequence of DVT, happening despite appropriate acute management. It affects 20% to 50% of patients within 2 years of DVT diagnosis, with severe forms in 5–10%. The condition usually involves the same limb affected by the original thrombosis, and symptoms may emerge shortly after the acute event or be delayed by months or even years.

Pathophysiology

Clot formation can injure venous valves and disrupt normal blood flow. Although anticoagulant therapy is effective in preventing clot propagation and pulmonary embolism, it does not actively remove the existing thrombus, often leaving residual blockage. Persistent obstruction and valve failure increase venous pressure, which over time drives inflammation, reduced oxygen delivery, and progressive chronic symptoms.

Clinical Presentation and Complications

PTS can vary widely in severity, ranging from mild, occasional discomfort to serious, long-lasting consequences. Symptoms may appear intermittently or persist chronically, sometimes continuing uninterrupted following the initial thrombotic event. Patients commonly report limb heaviness, aching, burning or throbbing soreness, itching, and swelling. Main complications include chronic pain, skin alterations, persistent edema, venous ulcers, infections, and reduced mobility.

The Psychological Impact

Beyond physical symptoms, the psychological burden of Post‑Thrombotic Syndrome is substantial. Patients frequently complain of reduced mobility and limitations in work or social activities. Additionally, many survivors experience PTSD-like symptoms, including flashbacks and intrusive thoughts related to the sudden, life-threatening nature of the original clot.

Predisposing Conditions

Post‑Thrombotic Syndrome is relatively common among individuals with prior DVT. Major risk factors include the location and extent of the initial thrombosis, delayed or inadequate anticoagulation, recurrent DVT episodes, and individual patient characteristics (e.g. obesity or advanced age). Thrombosis involving proximal veins, such as the femoral or iliac veins, carries a higher risk because of more extensive venous damage.

Diagnosis

Although PTS is common, it has no uniform diagnostic standard. Imaging studies and laboratory markers, including D‑dimer, may support evaluation but lack specificity. Consequently, diagnosis relies primarily on clinical assessment. Standardized scoring systems, such as the Villalta scale and the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification, are commonly used to identify PTS and grade its severity.

Management

Treatment of PTS focuses on symptom relief and prevention of disease progression. Strategies include lifestyle modifications, pharmacologic therapy, compression, and appropriate anticoagulation, with selected patients benefiting from thrombolysis, thrombectomy, or venous stenting. Chronic venous ulcers often require multidisciplinary care and may necessitate surgical or endovascular intervention when conservative measures are insufficient.

Conclusion and Outlook

PTS represents a significant longterm consequence of venous thrombosis. Even with appropriate anticoagulation, this syndrome remains difficult to recognize and manage. Improving awareness among clinicians and patients is essential to promote early recognition, structured follow‑up, and timely intervention, ultimately reducing the physical, psychological, and societal impact of this chronic condition.